GENERAL - VASCULAR INTERVENTION
Total Payments
$2.5M
Transactions
5,261
Doctors
2,637
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $213,271 | 61 | 42 |
| 2021 | $59,073 | 211 | 104 |
| 2020 | $1.6M | 2,829 | 1,516 |
| 2019 | $117,388 | 168 | 119 |
| 2018 | $232,736 | 90 | 66 |
| 2017 | $277,317 | 1,902 | 1,121 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.3M | 27 | 54.2% |
| Consulting Fee | $473,611 | 302 | 19.3% |
| Grant | $306,305 | 59 | 12.5% |
| Food and Beverage | $199,164 | 4,663 | 8.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $95,874 | 53 | 3.9% |
| Travel and Lodging | $39,108 | 153 | 1.6% |
| Charitable Contribution | $10,000 | 1 | 0.4% |
| Education | $683.10 | 3 | 0.0% |
Payments by Type
Research
$1.3M
27 transactions
General
$1.1M
5,234 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Project 1 Variation in Device Selection and Associated Outcomes for Peripheral Vascular Intervention | BOSTON SCIENTIFIC CORPORATION | $223,175 | 0 |
| Project 2 - Variation and Outcomes Associated with Device Selection for Pulmonary Embolism Intervention | BOSTON SCIENTIFIC CORPORATION | $223,175 | 0 |
| Project 3 - Socioeconomic and Racial Disparities in the Treatment of Peripheral Artery Disease | BOSTON SCIENTIFIC CORPORATION | $223,175 | 0 |
| Prime Registry | Boston Scientific Corporation | $168,750 | 0 |
| Time to Revascularization and Outcomes for Patients with Critical Limb Ischemia Establishing the Door to Limb D2L Time | BOSTON SCIENTIFIC CORPORATION | $112,050 | 0 |
| Expert Consensus Statement State of the Art and Current Use of IVUS in Non Coronary Vascular Disease Venous and Arterial | BOSTON SCIENTIFIC CORPORATION | $88,078 | 0 |
| A Clinical Study of Patients with PE Receiving Anticoagulation Along and a Similar Analysis of the OPTALYSEPE Trial BLUSH II & III | BOSTON SCIENTIFIC CORPORATION | $39,498 | 0 |
| Computational Fluid Dynamics for Peripheral Artery Disease | BOSTON SCIENTIFIC CORPORATION | $33,188 | 0 |
| The Importance of Proximal Iliac Vein Stenosis in Iliofemoral Deep Vein Thrombosis | BOSTON SCIENTIFIC CORPORATION | $30,000 | 0 |
| Thermal Imaging in Peripheral Arterial Disease to Determine Efficacy of Endovascular Revascularization | BOSTON SCIENTIFIC CORPORATION | $29,688 | 0 |
| Computational Fluid Dynamics for Peripheral Artery Disease | Boston Scientific Corporation | $29,250 | 0 |
| Quality of Life Metrics in a Young Population with Nonthrombotic Iliac Vein Compression Following Stenting of the Iliac Vein | BOSTON SCIENTIFIC CORPORATION | $28,000 | 0 |
| Varithena Manuscript Assistance | BOSTON SCIENTIFIC CORPORATION | $25,500 | 0 |
| XLPAD Study | Boston Scientific Corporation | $25,000 | 0 |
| Does Junctional Reflux Impact Symptoms and Patient Reported Outcomes of Isolated Greater Saphenous Vein GSV | BOSTON SCIENTIFIC CORPORATION | $23,750 | 0 |
| SENTRY Inferior vena cava IVC filter IVUS Study | BOSTON SCIENTIFIC CORPORATION | $20,684 | 0 |
| Outcomes in Patients Treated with Drug Coated Devices A Subgroup Analysis from VOYAGER PAD | BOSTON SCIENTIFIC CORPORATION | $7,250 | 0 |
| VascTrac: mHealth Peripheral Artery Disease Study | Boston Scientific Corporation | $3,000 | 0 |
Top Doctors Receiving Payments for GENERAL - VASCULAR INTERVENTION
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Providence, RI | $1.6M | 91 |
| , M.D | Internal Medicine | New York, NY | $50,000 | 1 |
| , MD | Internal Medicine | Morristown, NJ | $15,000 | 1 |
| , M.D | Vascular & Interventional Radiology | Chicago, IL | $14,655 | 8 |
| , MD | Specialist | New York, NY | $14,056 | 11 |
| , D.O | Internal Medicine | Greenbelt, MD | $12,506 | 6 |
| , MD | Vascular & Interventional Radiology | Indianapolis, IN | $12,120 | 14 |
| , M.D | Vascular Surgery | Centereach, NY | $11,169 | 8 |
| , MD | Cardiovascular Disease | New York, NY | $10,087 | 5 |
| , MD | Specialist | Bellevue, WA | $9,050 | 5 |
| , M.D | Vascular Surgery | Buffalo, NY | $8,640 | 25 |
| , M.D | Vascular & Interventional Radiology | Orange, CA | $8,250 | 4 |
| , MD | Vascular Surgery | Los Angeles, CA | $8,250 | 4 |
| , M.D | Cardiovascular Disease | Boston, MA | $8,250 | 3 |
| , MD | Internal Medicine | Enfield, CT | $8,250 | 4 |
| , M.D | Diagnostic Radiology | Milwaukee, WI | $7,849 | 6 |
| , M.D | Cardiovascular Disease | Denver, CO | $7,750 | 3 |
| , M.D | Vascular & Interventional Radiology | Chicago, IL | $7,485 | 8 |
| , MD, MSC | Cardiovascular Disease | Boston, MA | $7,250 | 2 |
| , M.D | Internal Medicine | Lubbock, TX | $7,205 | 6 |
| , M.D | Surgery | New York, NY | $7,054 | 10 |
| , MD | Surgery | Charlotte, NC | $7,002 | 4 |
| , M.D | Vascular & Interventional Radiology | Wilson, NC | $6,738 | 6 |
| , MD | Diagnostic Radiology | Miami Beach, FL | $6,552 | 12 |
| , M.D | Diagnostic Radiology | Washington, DC | $6,250 | 2 |
Ad
Manufacturing Companies
- BOSTON SCIENTIFIC CORPORATION $1.5M
- Boston Scientific Corporation $963,698
Product Information
- Type Device
- Total Payments $2.5M
- Total Doctors 2,637
- Transactions 5,261
About GENERAL - VASCULAR INTERVENTION
GENERAL - VASCULAR INTERVENTION is a device associated with $2.5M in payments to 2,637 healthcare providers, recorded across 5,261 transactions in the CMS Open Payments database. The primary manufacturer is BOSTON SCIENTIFIC CORPORATION.
Payment data is available from 2017 to 2022. In 2022, $213,271 was paid across 61 transactions to 42 doctors.
The most common payment nature for GENERAL - VASCULAR INTERVENTION is "Unspecified" ($1.3M, 54.2% of total).
GENERAL - VASCULAR INTERVENTION is associated with 18 research studies, including "Project 1 Variation in Device Selection and Associated Outcomes for Peripheral Vascular Intervention" ($223,175).